Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Gynecologic Oncology Program at the Susan F. Smith Center for Women’s Cancers is a leader in research and care for patients with gynecologic cancer, including ovarian cancer, endometrial/uterine cancer, cervical cancer, vulvar cancer, and vaginal cancers, as well as gestational trophoblastic disease. We offer a seamless blend of medical, surgical, radiation, and pathology expertise and develop personalized approaches based on a woman’s specific type of cancer, whether it is early-stage or advanced.
Center for BRCA and Related Genes Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers.
Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers.
New Patient Appointments 877-442-3324
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.
